Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Volume: 382, Issue: 20, Pages: 1894 - 1905
Published: May 14, 2020
Abstract
The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b trial involving patients with unresectable hepatocellular...
Paper Details
Title
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Published Date
May 14, 2020
Volume
382
Issue
20
Pages
1894 - 1905
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History